Skip to content

CAPSURE®SP NOVUS 5092-58 (UDI 00643169590687)Recalls & reported problems

Medtronic, Inc. · LEAD 5092-58 CAPSURE SP US BI SIL VENT · Class 3 · Implant

All models of CapSureSP Novus (14)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169590687), received between Aug 9, 2018 and Aug 9, 2018 — classified as 1 injury.

The most frequently reported specific device problem is “Over-Sensing” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Over-Sensing1
  • Signal Artifact/Noise1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 9, 2018Signal Artifact/Noise; Over-Sensing; Signal Artifact/Noise

    IT WAS REPORTED THAT THE RIGHT VENTRICULAR (RV) LEAD SHOWED NOISE DURING TWO VENTRICULAR HIGH RATE (VHR) EVENTS. THE LEAD WAS REPROGRAMMED AND REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7767883 ↗

Other permanent pacemaker Electrode devices

All permanent pacemaker Electrode devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page